Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Randomized, Double-blind, Placebo-controlled Study of Safety and Efficacy of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome® Gel) for the Treatment of Osteoarthritis of the Knee

NCT00722852 is registered in ClinicalTrials.gov with IDEA AG as lead sponsor.

NCT NCT00722852
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00722852 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Randomized, Double-blind, Placebo-controlled Study of Safety and Efficacy of Epicutaneously Applied Diractin® (Ketoprofen in Transfersome® Gel) for the Treatment of Osteoarthritis of the Knee
Lead sponsor
IDEA AG
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
April 30, 2009
Enrollment
555 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee